AI Signal Dashboard
Last updated: 03.19 21:43
Top Undervalued
+11¢
(Yes)
RFK Jr. Out by December 31? AI analysis: • +11¢ undervalued • Live Prediction Market fair value & mispricing alerts.
Undervalued Options Insights:
While the market's current pricing (26c) implies a 74% probability of RFK Jr. retaining his position...
Log in to see more
Real-time High Yield Opportunities
View MoreAll
Outcomes
Market
Price
AI Fair
Value
Value
Edge
YesNo
21¢
79¢
32¢
68¢
+11¢
0¢
⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.
Exotics
This is a typical political appointment tenure prediction. While cabinet turnover is a common topic, RFK Jr.'s controversial nature and anti-establishment stance make his tenure inherently uncertain and more of a 'spectacle' than standard cabinet predictions, elevating its novelty.
Hedging
MRNA
XBI
PFE
RFK Jr. is known for his anti-vaccine stance and skepticism of traditional pharma regulation. If he leaves (especially if forced out), the market would likely interpret this as a relief of regulatory pressure on Big Pharma, bullish for vaccine stocks (Moderna, Pfizer) and the Biotech ETF (XBI). Conversely, his continued tenure and potential radical policies could weigh on these assets. Thus, significant correlation exists with the healthcare sector.
Divergence
Significant divergence exists. Mainstream media and public health experts continuously highlight the conflict between RFK Jr.'s anti-vaccine stance and the scientific community, predicting 'dire consequences' and his eventual marginalization or forced resignation (high-risk view). However, the prediction market's ~26% probability of departure suggests traders believe his standing within Trump's inner circle is far more secure than media narratives suggest, pricing in political loyalty over policy controversy.